Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZD 7009 is a novel antiarrhythmic compound that inhibits the sodium current of hNav1.5 in CHO K1 cells with an IC50 of 11 uM. AZD 7009 inhibited late sodium current in isolated rabbit atrial and ventricular myocytes, and prolonged E-4031-induced action potential duration, promoting early post-depolarization of Purkinye fibers (EADs).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 144,500 |
5 mg | 在庫あり | ¥ 310,000 |
25 mg | 在庫あり | ¥ 615,000 |
50 mg | 在庫あり | ¥ 833,000 |
説明 | AZD 7009 is a novel antiarrhythmic compound that inhibits the sodium current of hNav1.5 in CHO K1 cells with an IC50 of 11 uM. AZD 7009 inhibited late sodium current in isolated rabbit atrial and ventricular myocytes, and prolonged E-4031-induced action potential duration, promoting early post-depolarization of Purkinye fibers (EADs). |
別名 | AZD-7009, AZD7009 |
分子量 | 446.54 |
分子式 | C23H34N4O5 |
CAS No. | 335619-18-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (134.37 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZD 7009 335619-18-6 Membrane transporter/Ion channel Sodium Channel AZD-7009 AZD7009 Inhibitor inhibitor inhibit